Abstract
Drug-induced vasculitis is defined as inflammation of blood vessels due to an adverse effect of a drug. Histologically, vasculitis is defined as an inflammatory cell-mediated infiltration and destruction of blood vessels. Vasculitis can be either primary, as seen in granulomatous polyangiits, or secondary, when associated with drugs, infection, malignancy, or connective tissue disease.
While the exact pathogenesis of drug-induced vasculitis remains unclear, it is strongly believed to be an immune-complex mediated process. Many drugs are associated with vasculitis and nearly every class of drug has been implicated. The most common drugs associated with vasculitis are propylthioruacil, hydralazine, minocycline, allopurinol, D-penicillamine, sulfasalazine, penicillins, cephalosporins and several immunomodulating agents, discussed below. Diagnosis of drug-induced vasculitis is often challenging, as there are no pathognomonic clinical or histological features to distinguish it from other causes of vasculitis. It is also very difficult to prove that an exposure to a drug led to cutaneous vasculitis. Severity of drug-induced vasculitis can range from mild, and self-limiting to severely progressive and even fatal. A high index of suspicion should be maintained for vasculitic lesions that arise in the setting of recent introduction of a new drug. Suspicious agents should be promptly withdrawn, as resolution often occurs soon after discontinuation of the offending drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005;7:R1072–81.
Calabrese LH, Duna GF. Drug-induced vasculitis. Curr Opin Rheumatol. 1996;8:34–40.
Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol. 2006;24:414–29.
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27:504–28.
Chastain MA, Russo GG, Boh EE, Chastain JB, Falabella A, Millikan LE. Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature. J Am Acad Dermatol. 1999;41:757–64.
Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9:71–92.
Cid MC, Segarra M, Garcia-Martinez A, Hernandez-Rodriguez J. Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis. Curr Rheumatol Rep. 2004;6:184–94.
Cuellar ML. Drug-induced vasculitis. Curr Rheumatol Rep. 2002;4:55–9.
Gaertner EM, Switlyk SA. Dermatologic complications from levamisole-contaminated cocaine: a case report and review of the literature. Cutis. 2014;93:102–6.
Hennings C, Miller J. Illicit drugs: what dermatologists need to know. J Amer Acad Dermatol. 2013;69:135–42.
Lenert P, Icardi M, Dahmoush L. ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review. Clin Rheumatol. 2013;32:1099–106.
Merkel PA. Drugs associated with vasculitis. Curr Opin Rheumatol. 1998;10:45–50.
Merkel PA. Drug-induced vasculitis. Rheum Dis Clin North Am. 2001;27:849–62.
Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol. 2004;31:1955–8.
Pearson T, Bremmer M, Cohen J, Driscoll M. Vasculopathy related to cocaine adulterated with levimasole: a review of the literature. Dermatol Online J. 2012;18:1.
Pendergraft III WF, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol. 2014;26:42–9.
Sokumbi O, Welter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-alpha inhibitors. Mayo Clin Proc. 2012;87:739–45.
Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol. 2008;20:35–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Rivas, S., Pandya, A.G., Dominguez, A.R. (2015). Drug-Induced Vasculitis. In: Hall, J., Hall, B. (eds) Cutaneous Drug Eruptions. Springer, London. https://doi.org/10.1007/978-1-4471-6729-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6729-7_8
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6728-0
Online ISBN: 978-1-4471-6729-7
eBook Packages: MedicineMedicine (R0)